25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

PharmChem Inc
Buy, Hold or Sell?

Let's analyze PharmChem Inc together

I guess you are interested in PharmChem Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of PharmChem Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about PharmChem Inc

I send you an email if I find something interesting about PharmChem Inc.

1. Quick Overview

1.1. Quick analysis of PharmChem Inc (30 sec.)










1.2. What can you expect buying and holding a share of PharmChem Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
11.1%

What is your share worth?

Current worth
$0.59
Expected worth in 1 year
$0.68
How sure are you?
77.8%

+ What do you gain per year?

Total Gains per Share
$0.09
Return On Investment
2.9%

For what price can you sell your share?

Current Price per Share
$3.10
Expected price per share
$2.3356515384615 - $3.4
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of PharmChem Inc (5 min.)




Live pricePrice per Share (EOD)
$3.10

2.2. Growth of PharmChem Inc (5 min.)




Is PharmChem Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$2.7m$3m-$526.9k-21.3%

How much money is PharmChem Inc making?

Current yearPrevious yearGrowGrow %
Making money$315.5k$191.4k$124k39.3%
Net Profit Margin21.1%13.3%--

How much money comes from the company's main activities?

2.3. Financial Health of PharmChem Inc (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of PharmChem Inc?

Welcome investor! PharmChem Inc's management wants to use your money to grow the business. In return you get a share of PharmChem Inc.

First you should know what it really means to hold a share of PharmChem Inc. And how you can make/lose money.

Speculation

The Price per Share of PharmChem Inc is $3.1. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of PharmChem Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in PharmChem Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.59. Based on the TTM, the Book Value Change Per Share is $0.02 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of PharmChem Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.124.0%0.072.2%0.041.2%0.051.6%0.051.6%
Usd Book Value Change Per Share0.082.5%0.020.7%-0.03-0.8%-0.08-2.5%-0.08-2.5%
Usd Dividend Per Share0.000.0%0.000.0%0.051.6%0.020.7%0.020.7%
Usd Total Gains Per Share0.082.5%0.020.7%0.020.8%-0.06-1.8%-0.06-1.8%
Usd Price Per Share3.65-2.88-2.50-2.70-2.70-
Price to Earnings Ratio7.41-12.85-18.02-16.48-16.48-
Price-to-Total Gains Ratio46.42-78.82-118.60-87.29-87.29-
Price to Book Ratio6.18-5.49-4.51-4.96-4.96-
Price-to-Total Gains Ratio46.42-78.82-118.60-87.29-87.29-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.1
Number of shares322
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.02
Usd Book Value Change Per Share0.02-0.08
Usd Total Gains Per Share0.02-0.06
Gains per Quarter (322 shares)7.12-17.86
Gains per Year (322 shares)28.48-71.43
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10281828-100-81
20574657-200-152
30857485-299-223
40114102113-399-294
50142130142-499-365
60171158170-599-436
70199186198-698-507
80228214227-798-578
90256242255-898-649
100285270283-998-720

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%28.020.00.058.3%
Book Value Change Per Share3.01.00.075.0%6.03.00.066.7%6.03.00.066.7%6.03.00.066.7%25.023.00.052.1%
Dividend per Share0.00.04.00.0%1.00.08.011.1%1.00.08.011.1%1.00.08.011.1%1.00.047.02.1%
Total Gains per Share3.01.00.075.0%7.02.00.077.8%7.02.00.077.8%7.02.00.077.8%26.022.00.054.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of PharmChem Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0790.022+256%-0.025+132%-0.077+199%-0.077+199%
Book Value Per Share--0.5900.522+13%0.570+4%0.552+7%0.552+7%
Current Ratio--5.4945.219+5%11.060-50%8.152-33%8.152-33%
Debt To Asset Ratio--0.1890.199-5%0.143+32%0.166+14%0.166+14%
Debt To Equity Ratio--0.2330.249-6%0.169+38%0.201+16%0.201+16%
Dividend Per Share----0%0.049-100%0.022-100%0.022-100%
Eps--0.1230.067+84%0.036+239%0.049+151%0.049+151%
Free Cash Flow Per Share--0.1080.059+82%0.064+70%0.057+89%0.057+89%
Free Cash Flow To Equity Per Share--0.1080.012+799%-0.011+110%0.000+45972%0.000+45972%
Gross Profit Margin--1.0000.678+47%0.733+36%0.738+35%0.738+35%
Market Cap14407963.000-18%16964218.15013628781.878+24%13066712.383+30%13488520.382+26%13488520.382+26%
Net Profit Margin--0.3710.211+76%0.133+180%0.163+127%0.163+127%
Operating Margin--0.4400.251+75%0.155+184%0.195+125%0.195+125%
Operating Ratio--0.5740.759-24%0.845-32%0.809-29%0.809-29%
Pb Ratio5.251-18%6.1835.489+13%4.515+37%4.963+25%4.963+25%
Pe Ratio6.293-18%7.40912.852-42%18.017-59%16.475-55%16.475-55%
Price Per Share3.100-18%3.6502.880+27%2.499+46%2.702+35%2.702+35%
Price To Free Cash Flow Ratio7.160-18%8.43013.692-38%22.957-63%19.787-57%19.787-57%
Price To Total Gains Ratio39.428-18%46.42378.821-41%118.595-61%87.287-47%87.287-47%
Quick Ratio--4.9574.542+9%10.202-51%7.364-33%7.364-33%
Return On Assets--0.1690.101+68%0.054+211%0.074+130%0.074+130%
Return On Equity--0.2090.125+66%0.064+228%0.089+134%0.089+134%
Total Gains Per Share--0.0790.022+256%0.024+223%-0.055+171%-0.055+171%
Usd Book Value--2743741.0002474447.500+11%3001370.750-9%2783002.222-1%2783002.222-1%
Usd Book Value Change Per Share--0.0790.022+256%-0.025+132%-0.077+199%-0.077+199%
Usd Book Value Per Share--0.5900.522+13%0.570+4%0.552+7%0.552+7%
Usd Dividend Per Share----0%0.049-100%0.022-100%0.022-100%
Usd Eps--0.1230.067+84%0.036+239%0.049+151%0.049+151%
Usd Free Cash Flow--503080.000280573.250+79%339111.750+48%288306.000+74%288306.000+74%
Usd Free Cash Flow Per Share--0.1080.059+82%0.064+70%0.057+89%0.057+89%
Usd Free Cash Flow To Equity Per Share--0.1080.012+799%-0.011+110%0.000+45972%0.000+45972%
Usd Market Cap14407963.000-18%16964218.15013628781.878+24%13066712.383+30%13488520.382+26%13488520.382+26%
Usd Price Per Share3.100-18%3.6502.880+27%2.499+46%2.702+35%2.702+35%
Usd Profit--572407.000315581.750+81%191489.750+199%241736.778+137%241736.778+137%
Usd Revenue--1541543.0001488635.500+4%1458639.750+6%1477468.889+4%1477468.889+4%
Usd Total Gains Per Share--0.0790.022+256%0.024+223%-0.055+171%-0.055+171%
 EOD+4 -4MRQTTM+31 -3YOY+26 -105Y+26 -1010Y+26 -10

3.3 Fundamental Score

Let's check the fundamental score of PharmChem Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-156.293
Price to Book Ratio (EOD)Between0-15.251
Net Profit Margin (MRQ)Greater than00.371
Operating Margin (MRQ)Greater than00.440
Quick Ratio (MRQ)Greater than14.957
Current Ratio (MRQ)Greater than15.494
Debt to Asset Ratio (MRQ)Less than10.189
Debt to Equity Ratio (MRQ)Less than10.233
Return on Equity (MRQ)Greater than0.150.209
Return on Assets (MRQ)Greater than0.050.169
Total9/10 (90.0%)

3.4 Technical Score

Let's check the technical score of PharmChem Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.594
Ma 20Greater thanMa 503.263
Ma 50Greater thanMa 1003.426
Ma 100Greater thanMa 2003.379
OpenGreater thanClose3.100
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About PharmChem Inc

PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas.

Fundamental data was last updated by Penke on 2024-11-27 11:50:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit PharmChem Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare PharmChem Inc to the Medical Devices industry mean.
  • A Net Profit Margin of 37.1% means that $0.37 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of PharmChem Inc:

  • The MRQ is 37.1%. The company is making a huge profit. +2
  • The TTM is 21.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ37.1%TTM21.1%+16.0%
TTM21.1%YOY13.3%+7.8%
TTM21.1%5Y16.3%+4.7%
5Y16.3%10Y16.3%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ37.1%-6.4%+43.5%
TTM21.1%-15.3%+36.4%
YOY13.3%-15.4%+28.7%
5Y16.3%-18.1%+34.4%
10Y16.3%-23.4%+39.7%
4.3.1.2. Return on Assets

Shows how efficient PharmChem Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare PharmChem Inc to the Medical Devices industry mean.
  • 16.9% Return on Assets means that PharmChem Inc generated $0.17 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of PharmChem Inc:

  • The MRQ is 16.9%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 10.1%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ16.9%TTM10.1%+6.8%
TTM10.1%YOY5.4%+4.6%
TTM10.1%5Y7.4%+2.7%
5Y7.4%10Y7.4%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ16.9%-2.0%+18.9%
TTM10.1%-3.2%+13.3%
YOY5.4%-4.0%+9.4%
5Y7.4%-3.0%+10.4%
10Y7.4%-4.0%+11.4%
4.3.1.3. Return on Equity

Shows how efficient PharmChem Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare PharmChem Inc to the Medical Devices industry mean.
  • 20.9% Return on Equity means PharmChem Inc generated $0.21 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of PharmChem Inc:

  • The MRQ is 20.9%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 12.5%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ20.9%TTM12.5%+8.3%
TTM12.5%YOY6.4%+6.2%
TTM12.5%5Y8.9%+3.6%
5Y8.9%10Y8.9%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ20.9%-2.4%+23.3%
TTM12.5%-3.8%+16.3%
YOY6.4%-4.4%+10.8%
5Y8.9%-3.9%+12.8%
10Y8.9%-5.4%+14.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of PharmChem Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient PharmChem Inc is operating .

  • Measures how much profit PharmChem Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare PharmChem Inc to the Medical Devices industry mean.
  • An Operating Margin of 44.0% means the company generated $0.44  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of PharmChem Inc:

  • The MRQ is 44.0%. The company is operating very efficient. +2
  • The TTM is 25.1%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ44.0%TTM25.1%+18.8%
TTM25.1%YOY15.5%+9.6%
TTM25.1%5Y19.5%+5.6%
5Y19.5%10Y19.5%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ44.0%-12.3%+56.3%
TTM25.1%-18.2%+43.3%
YOY15.5%-13.9%+29.4%
5Y19.5%-17.7%+37.2%
10Y19.5%-21.0%+40.5%
4.3.2.2. Operating Ratio

Measures how efficient PharmChem Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.57 means that the operating costs are $0.57 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of PharmChem Inc:

  • The MRQ is 0.574. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.759. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.574TTM0.759-0.185
TTM0.759YOY0.845-0.086
TTM0.7595Y0.809-0.051
5Y0.80910Y0.8090.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5741.282-0.708
TTM0.7591.336-0.577
YOY0.8451.329-0.484
5Y0.8091.374-0.565
10Y0.8091.321-0.512
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of PharmChem Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if PharmChem Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 5.49 means the company has $5.49 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of PharmChem Inc:

  • The MRQ is 5.494. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.219. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.494TTM5.219+0.274
TTM5.219YOY11.060-5.840
TTM5.2195Y8.152-2.933
5Y8.15210Y8.1520.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ5.4942.567+2.927
TTM5.2192.636+2.583
YOY11.0602.922+8.138
5Y8.1523.415+4.737
10Y8.1523.527+4.625
4.4.3.2. Quick Ratio

Measures if PharmChem Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare PharmChem Inc to the Medical Devices industry mean.
  • A Quick Ratio of 4.96 means the company can pay off $4.96 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of PharmChem Inc:

  • The MRQ is 4.957. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.542. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.957TTM4.542+0.415
TTM4.542YOY10.202-5.660
TTM4.5425Y7.364-2.822
5Y7.36410Y7.3640.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.9571.474+3.483
TTM4.5421.688+2.854
YOY10.2021.840+8.362
5Y7.3642.330+5.034
10Y7.3642.545+4.819
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of PharmChem Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of PharmChem Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare PharmChem Inc to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.19 means that PharmChem Inc assets are financed with 18.9% credit (debt) and the remaining percentage (100% - 18.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of PharmChem Inc:

  • The MRQ is 0.189. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.199. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.189TTM0.199-0.010
TTM0.199YOY0.143+0.056
TTM0.1995Y0.166+0.033
5Y0.16610Y0.1660.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1890.407-0.218
TTM0.1990.401-0.202
YOY0.1430.360-0.217
5Y0.1660.437-0.271
10Y0.1660.457-0.291
4.5.4.2. Debt to Equity Ratio

Measures if PharmChem Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare PharmChem Inc to the Medical Devices industry mean.
  • A Debt to Equity ratio of 23.3% means that company has $0.23 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of PharmChem Inc:

  • The MRQ is 0.233. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.249. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.233TTM0.249-0.015
TTM0.249YOY0.169+0.080
TTM0.2495Y0.201+0.048
5Y0.20110Y0.2010.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2330.552-0.319
TTM0.2490.589-0.340
YOY0.1690.530-0.361
5Y0.2010.630-0.429
10Y0.2010.698-0.497
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings PharmChem Inc generates.

  • Above 15 is considered overpriced but always compare PharmChem Inc to the Medical Devices industry mean.
  • A PE ratio of 7.41 means the investor is paying $7.41 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of PharmChem Inc:

  • The EOD is 6.293. Based on the earnings, the company is cheap. +2
  • The MRQ is 7.409. Based on the earnings, the company is cheap. +2
  • The TTM is 12.852. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD6.293MRQ7.409-1.116
MRQ7.409TTM12.852-5.443
TTM12.852YOY18.017-5.165
TTM12.8525Y16.475-3.623
5Y16.47510Y16.4750.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD6.293-1.054+7.347
MRQ7.409-1.367+8.776
TTM12.852-1.961+14.813
YOY18.017-2.111+20.128
5Y16.475-2.112+18.587
10Y16.475-2.205+18.680
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of PharmChem Inc:

  • The EOD is 7.160. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 8.430. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 13.692. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD7.160MRQ8.430-1.270
MRQ8.430TTM13.692-5.262
TTM13.692YOY22.957-9.265
TTM13.6925Y19.787-6.096
5Y19.78710Y19.7870.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD7.160-1.404+8.564
MRQ8.430-1.767+10.197
TTM13.692-1.904+15.596
YOY22.957-5.503+28.460
5Y19.787-3.987+23.774
10Y19.787-4.789+24.576
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of PharmChem Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 6.18 means the investor is paying $6.18 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of PharmChem Inc:

  • The EOD is 5.251. Based on the equity, the company is overpriced. -1
  • The MRQ is 6.183. Based on the equity, the company is overpriced. -1
  • The TTM is 5.489. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD5.251MRQ6.183-0.932
MRQ6.183TTM5.489+0.693
TTM5.489YOY4.515+0.975
TTM5.4895Y4.963+0.527
5Y4.96310Y4.9630.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD5.2512.132+3.119
MRQ6.1832.144+4.039
TTM5.4892.378+3.111
YOY4.5153.034+1.481
5Y4.9634.091+0.872
10Y4.9634.646+0.317
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. All numbers in thousands.

Summary
Total Assets3,384
Total Liabilities641
Total Stockholder Equity2,744
 As reported
Total Liabilities 641
Total Stockholder Equity+ 2,744
Total Assets = 3,384

Assets

Total Assets3,384
Total Current Assets3,319
Long-term Assets65
Total Current Assets
Cash And Cash Equivalents 2,304
Net Receivables 691
Inventory 176
Other Current Assets 148
Total Current Assets  (as reported)3,319
Total Current Assets  (calculated)3,319
+/-0
Long-term Assets
Property Plant Equipment 63
Intangible Assets 2
Long-term Assets Other 0
Long-term Assets  (as reported)65
Long-term Assets  (calculated)65
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities604
Long-term Liabilities36
Total Stockholder Equity2,744
Total Current Liabilities
Short-term Debt 28
Accounts payable 179
Other Current Liabilities 218
Total Current Liabilities  (as reported)604
Total Current Liabilities  (calculated)425
+/- 179
Long-term Liabilities
Long-term Liabilities  (as reported)36
Long-term Liabilities  (calculated)0
+/- 36
Total Stockholder Equity
Common Stock5
Retained Earnings -9,542
Other Stockholders Equity 12,281
Total Stockholder Equity (as reported)2,744
Total Stockholder Equity (calculated)2,744
+/-0
Other
Cash and Short Term Investments 2,304
Common Stock Shares Outstanding 4,648
Current Deferred Revenue179
Liabilities and Stockholders Equity 3,384
Net Debt -2,240
Net Working Capital 2,715
Short Long Term Debt Total 64



6.2. Balance Sheets Structured

All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-301995-06-301995-03-311994-12-311994-09-301994-06-301994-03-311993-12-311993-09-301993-06-301993-03-311992-12-311992-09-301992-06-301992-03-311991-12-311991-09-301991-06-301991-03-311990-12-311990-09-301990-06-301990-03-311989-12-311989-09-301989-06-301989-03-31
> Total Assets 
0
0
0
9,600
0
0
0
11,200
0
0
0
27,100
0
0
0
31,500
0
30,700
26,600
29,000
28,800
0
27,800
28,300
28,300
0
30,900
22,200
22,700
22,800
21,900
21,468
20,300
21,900
22,200
22,096
21,900
23,700
23,100
22,063
22,500
23,600
24,800
25,046
25,452
26,357
26,771
27,265
27,463
27,428
29,660
28,497
28,224
25,325
23,721
22,667
20,829
19,851
18,458
16,662
14,855
3,577
3,803
4,082
2,910
3,155
3,252
2,766
2,953
3,384
3,3842,9532,7663,2523,1552,9104,0823,8033,57714,85516,66218,45819,85120,82922,66723,72125,32528,22428,49729,66027,42827,46327,26526,77126,35725,45225,04624,80023,60022,50022,06323,10023,70021,90022,09622,20021,90020,30021,46821,90022,80022,70022,20030,900028,30028,30027,800028,80029,00026,60030,700031,50000027,10000011,2000009,600000
   > Total Current Assets 
0
0
0
4,400
0
0
0
5,700
0
0
0
20,300
0
0
0
14,900
0
12,500
11,500
12,800
12,500
0
11,800
12,000
11,900
0
14,400
12,000
11,500
11,900
10,800
10,544
9,600
10,800
10,700
10,045
9,700
11,300
10,600
9,568
10,100
11,000
12,100
11,599
11,893
12,382
12,577
12,793
12,559
11,407
12,453
11,072
14,567
11,927
10,553
9,824
8,391
7,837
6,796
6,283
4,943
3,576
3,802
4,052
2,909
3,155
3,251
2,640
2,882
3,319
3,3192,8822,6403,2513,1552,9094,0523,8023,5764,9436,2836,7967,8378,3919,82410,55311,92714,56711,07212,45311,40712,55912,79312,57712,38211,89311,59912,10011,00010,1009,56810,60011,3009,70010,04510,70010,8009,60010,54410,80011,90011,50012,00014,400011,90012,00011,800012,50012,80011,50012,500014,90000020,3000005,7000004,400000
       Cash And Cash Equivalents 
0
0
0
900
0
0
0
500
0
0
0
13,800
0
0
0
6,200
0
3,400
2,600
2,800
1,900
0
1,000
1,000
600
0
1,600
600
300
100
300
240
400
300
500
372
200
600
900
802
1,000
1,100
1,100
1,804
1,491
1,530
1,272
1,714
1,756
1,045
1,040
1,137
7,265
5,085
4,155
4,213
2,917
2,426
1,581
1,693
626
2,254
2,814
3,283
2,015
2,079
2,096
1,572
1,801
2,304
2,3041,8011,5722,0962,0792,0153,2832,8142,2546261,6931,5812,4262,9174,2134,1555,0857,2651,1371,0401,0451,7561,7141,2721,5301,4911,8041,1001,1001,0008029006002003725003004002403001003006001,60006001,0001,00001,9002,8002,6003,40006,20000013,800000500000900000
       Net Receivables 
0
0
0
2,800
0
0
0
4,100
0
0
0
5,000
0
0
0
6,800
0
6,100
5,900
6,700
7,200
0
8,200
8,700
9,200
0
10,500
9,000
8,900
9,600
8,600
8,168
7,400
7,900
8,000
7,608
7,400
8,600
7,400
6,522
6,700
7,600
8,600
6,716
7,168
7,652
8,272
8,004
7,581
6,898
7,578
6,402
4,951
4,790
4,146
3,792
3,926
3,851
3,999
0
0
908
678
581
685
695
728
636
710
691
691710636728695685581678908003,9993,8513,9263,7924,1464,7904,9516,4027,5786,8987,5818,0048,2727,6527,1686,7168,6007,6006,7006,5227,4008,6007,4007,6088,0007,9007,4008,1688,6009,6008,9009,00010,50009,2008,7008,20007,2006,7005,9006,10006,8000005,0000004,1000002,800000
       Other Current Assets 
0
0
0
200
0
0
0
200
0
0
0
500
0
0
0
600
0
1,400
1,500
1,700
1,500
0
700
600
700
0
700
700
600
900
800
1,122
900
800
800
456
600
500
600
719
900
800
700
1,145
1,357
1,417
1,297
1,220
1,346
1,777
1,181
1,229
510
447
500
501
396
505
241
4,590
4,317
95
72
26
83
97
132
40
120
148
1481204013297832672954,3174,5902415053965015004475101,2291,1811,7771,3461,2201,2971,4171,3571,1457008009007196005006004568008009001,122800900600700700070060070001,5001,7001,5001,4000600000500000200000200000
   > Long-term Assets 
0
0
0
5,200
0
0
0
5,500
0
0
0
6,800
0
0
0
16,600
0
18,200
15,100
16,200
16,300
0
16,000
16,300
16,400
0
16,500
10,200
11,200
10,900
11,100
10,924
10,700
11,100
11,500
12,051
12,200
12,400
12,500
12,495
12,400
12,600
12,700
13,447
13,559
13,975
14,194
14,472
14,904
16,021
17,207
17,425
13,657
13,398
13,168
12,843
12,438
12,014
11,662
0
0
1
1
30
0
0
0
126
71
65
657112600030110011,66212,01412,43812,84313,16813,39813,65717,42517,20716,02114,90414,47214,19413,97513,55913,44712,70012,60012,40012,49512,50012,40012,20012,05111,50011,10010,70010,92411,10010,90011,20010,20016,500016,40016,30016,000016,30016,20015,10018,200016,6000006,8000005,5000005,200000
       Property Plant Equipment 
0
0
0
2,400
0
0
0
2,700
0
0
0
4,000
0
0
0
6,200
0
7,000
6,700
7,200
7,000
0
6,700
6,700
6,600
0
6,700
5,400
6,400
6,200
6,400
6,578
6,400
6,800
7,200
7,638
7,900
8,000
8,100
8,508
8,600
8,900
9,000
9,555
9,726
10,251
10,694
11,026
11,372
12,664
13,962
14,199
12,857
12,630
12,400
12,074
11,670
11,246
10,859
10,340
9,873
1
1
0
0
0
0
77
70
63
6370770000119,87310,34010,85911,24611,67012,07412,40012,63012,85714,19913,96212,66411,37211,02610,69410,2519,7269,5559,0008,9008,6008,5088,1008,0007,9007,6387,2006,8006,4006,5786,4006,2006,4005,4006,70006,6006,7006,70007,0007,2006,7007,00006,2000004,0000002,7000002,400000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,360
0
0
0
3,175
0
0
0
2,990
0
0
0
2,805
2,759
2,713
2,666
2,620
2,574
2,528
2,482
2,435
729
729
729
729
729
729
729
0
0
0
0
0
0
0
0
0
0
0
000000000007297297297297297297292,4352,4822,5282,5742,6202,6662,7132,7592,8050002,9900003,1750003,3600000000000000000000000000000000
       Intangible Assets 
0
0
0
2,300
0
0
0
2,200
0
0
0
2,000
0
0
0
8,600
0
8,400
5,900
7,800
8,000
0
5,800
5,800
5,700
0
5,600
3,500
3,500
3,500
3,400
0
3,300
3,300
3,200
0
3,100
3,100
3,000
0
2,900
2,900
2,900
0
0
0
0
0
0
0
0
2,435
729
729
729
729
729
0
0
0
0
0
0
0
0
0
0
0
0
2
20000000000007297297297297292,435000000002,9002,9002,90003,0003,1003,10003,2003,3003,30003,4003,5003,5003,5005,60005,7005,8005,80008,0007,8005,9008,40008,6000002,0000002,2000002,300000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,833
3,724
3,500
3,446
3,532
3,357
3,245
3,226
800
768
768
769
768
39
74
39
39
0
0
0
0
0
0
0
0
0
000000000393974397687697687688003,2263,2453,3573,5323,4463,5003,7243,83300000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
3,000
0
0
0
4,000
0
0
0
4,600
0
0
0
9,900
0
8,800
8,200
11,300
11,300
0
10,300
10,500
10,400
0
12,600
11,200
11,800
11,800
10,800
10,181
9,300
11,200
12,100
11,967
11,900
13,400
12,400
11,153
11,100
11,900
12,200
11,349
11,466
12,134
12,197
12,270
13,304
18,766
22,268
21,759
16,881
14,190
13,411
12,308
11,203
10,780
9,098
8,409
7,230
433
433
447
443
622
683
559
575
641
6415755596836224434474334337,2308,4099,09810,78011,20312,30813,41114,19016,88121,75922,26818,76613,30412,27012,19712,13411,46611,34912,20011,90011,10011,15312,40013,40011,90011,96712,10011,2009,30010,18110,80011,80011,80011,20012,600010,40010,50010,300011,30011,3008,2008,80009,9000004,6000004,0000003,000000
   > Total Current Liabilities 
0
0
0
2,100
0
0
0
2,900
0
0
0
3,000
0
0
0
7,000
0
6,200
5,500
8,800
8,400
0
7,900
7,800
7,900
0
10,200
7,800
8,100
7,100
7,600
8,837
8,100
10,000
11,100
11,124
10,800
12,300
11,400
9,887
9,000
9,300
9,800
8,559
9,034
10,022
10,007
10,386
10,174
17,032
18,905
17,325
14,059
11,583
12,352
11,494
10,597
7,154
5,519
8,302
7,176
433
162
447
443
622
683
508
531
604
6045315086836224434471624337,1768,3025,5197,15410,59711,49412,35211,58314,05917,32518,90517,03210,17410,38610,00710,0229,0348,5599,8009,3009,0009,88711,40012,30010,80011,12411,10010,0008,1008,8377,6007,1008,1007,80010,20007,9007,8007,90008,4008,8005,5006,20007,0000003,0000002,9000002,100000
       Short-term Debt 
0
0
0
1,100
0
0
0
1,200
0
0
0
900
0
0
0
3,900
0
3,400
3,500
5,700
4,900
0
3,700
3,800
3,500
0
3,600
1,200
1,300
1,400
1,400
2,335
2,600
3,700
4,600
4,584
3,900
4,900
3,600
2,844
2,000
1,900
2,200
1,475
2,863
3,252
2,949
2,099
3,349
7,160
7,455
7,693
6,398
5,064
6,103
5,722
5,441
1,879
1,221
0
0
0
0
0
0
0
0
27
27
28
282727000000001,2211,8795,4415,7226,1035,0646,3987,6937,4557,1603,3492,0992,9493,2522,8631,4752,2001,9002,0002,8443,6004,9003,9004,5844,6003,7002,6002,3351,4001,4001,3001,2003,60003,5003,8003,70004,9005,7003,5003,40003,9000009000001,2000001,100000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,722
5,441
1,879
1,221
1,878
829
0
0
0
0
0
0
0
0
0
0000000008291,8781,2211,8795,4415,7220000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
600
0
0
0
0
0
0
0
1,300
0
0
0
2,000
0
1,900
1,100
2,100
2,400
0
3,100
2,800
2,500
0
2,900
3,800
3,900
2,300
1,700
3,238
2,300
3,400
3,100
3,322
3,400
3,500
3,500
3,123
2,700
3,100
3,300
2,903
2,549
2,631
3,101
4,097
3,186
4,732
6,773
6,312
4,566
3,537
3,046
2,918
2,668
2,153
1,889
0
1
195
162
146
232
235
210
160
262
179
179262160210235232146162195101,8892,1532,6682,9183,0463,5374,5666,3126,7734,7323,1864,0973,1012,6312,5492,9033,3003,1002,7003,1233,5003,5003,4003,3223,1003,4002,3003,2381,7002,3003,9003,8002,90002,5002,8003,10002,4002,1001,1001,90002,0000001,3000000000600000
       Other Current Liabilities 
0
0
0
400
0
0
0
1,700
0
0
0
800
0
0
0
1,100
0
900
900
1,000
1,100
0
1,100
1,200
1,900
0
3,700
2,800
2,900
3,400
4,500
3,264
3,200
2,900
3,400
3,218
3,500
3,900
4,300
3,920
4,300
4,300
4,300
4,181
3,622
4,139
3,957
4,190
3,639
5,140
4,677
3,320
3,095
2,982
3,203
2,854
2,488
3,122
2,409
3,929
4,406
120
0
144
70
178
270
128
85
218
218851282701787014401204,4063,9292,4093,1222,4882,8543,2032,9823,0953,3204,6775,1403,6394,1903,9574,1393,6224,1814,3004,3004,3003,9204,3003,9003,5003,2183,4002,9003,2003,2644,5003,4002,9002,8003,70001,9001,2001,10001,1001,00090090001,1000008000001,700000400000
   > Long-term Liabilities 
0
0
0
1,000
0
0
0
1,200
0
0
0
1,600
0
0
0
2,900
0
2,700
2,700
2,500
2,900
0
2,300
2,800
2,500
0
2,500
3,400
3,700
4,700
3,200
1,344
1,100
1,000
800
843
600
500
500
1,266
1,800
2,400
2,100
2,790
2,432
2,112
2,190
1,884
3,130
1,734
3,363
4,434
2,822
2,607
1,059
814
606
3,626
3,579
0
0
0
271
0
0
0
0
51
43
36
36435100002710003,5793,6266068141,0592,6072,8224,4343,3631,7343,1301,8842,1902,1122,4322,7902,1002,4001,8001,2665005006008438001,0001,1001,3443,2004,7003,7003,4002,50002,5002,8002,30002,9002,5002,7002,70002,9000001,6000001,2000001,000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
183
167
154
153
145
142
101
98
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000009810114214515315416718300000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
6,600
0
0
0
7,200
0
0
0
22,500
0
0
0
21,600
0
21,900
18,400
17,700
17,500
0
17,500
17,800
17,900
0
18,300
11,000
10,900
11,000
11,100
11,287
11,000
10,700
10,100
10,129
10,000
10,300
10,700
10,910
11,400
11,700
12,600
13,697
13,986
14,223
14,574
14,995
14,159
8,662
7,392
6,738
11,343
11,135
10,310
10,359
9,626
9,071
9,360
8,253
7,625
3,144
3,385
3,635
2,467
2,534
2,569
2,207
2,378
2,744
2,7442,3782,2072,5692,5342,4673,6353,3853,1447,6258,2539,3609,0719,62610,35910,31011,13511,3436,7387,3928,66214,15914,99514,57414,22313,98613,69712,60011,70011,40010,91010,70010,30010,00010,12910,10010,70011,00011,28711,10011,00010,90011,00018,300017,90017,80017,500017,50017,70018,40021,900021,60000022,5000007,2000006,600000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,915
0
0
0
19,027
0
0
0
19,090
0
19,100
19,100
19,139
19,179
6
6
6
6
6
6
6
6
6
6
6
6
6
6
8,253
7,625
5
5
5
5
5
5
5
5
5
5555555557,6258,2536666666666666619,17919,13919,10019,100019,09000019,02700018,9150000000000000000000000000000000
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
83
0
0
0
21
-12
-152
-207
-142
-278
-229
-172
-279
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000-279-172-229-278-142-207-152-122100083000000000000000000000000000000000000000
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
8,100
0
0
0
8,200
0
0
0
21,800
0
0
0
18,700
0
18,700
18,600
18,600
18,600
0
18,600
18,700
18,700
0
18,700
18,700
18,800
18,800
18,700
0
19,000
19,000
19,000
0
19,100
19,100
19,200
0
19,100
-100
0
0
0
19,176
19,179
19,233
19,233
19,244
19,589
19,589
19,589
19,589
19,589
19,589
19,589
19,589
19,630
0
0
13,697
13,716
13,736
13,444
13,333
13,145
12,475
12,488
12,281
12,28112,48812,47513,14513,33313,44413,73613,71613,6970019,63019,58919,58919,58919,58919,58919,58919,58919,58919,24419,23319,23319,17919,176000-10019,100019,20019,10019,100019,00019,00019,000018,70018,80018,80018,70018,700018,70018,70018,600018,60018,60018,60018,700018,70000021,8000008,2000008,100000



6.3. Balance Sheets

All numbers in thousands.




6.4. Cash Flows

All numbers in thousands.




6.5. Income Statements

All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. All numbers in thousands.

Gross Profit (+$)
totalRevenue6,012
Cost of Revenue-2,108
Gross Profit3,9043,904
 
Operating Income (+$)
Gross Profit3,904
Operating Expense-2,931
Operating Income973973
 
Operating Expense (+$)
Research Development2
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense2,9312
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income973
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,054893
EBIT - interestExpense = 1,054
1,054
845
Interest Expense0
Earnings Before Interest and Taxes (EBIT)1,0541,054
Earnings Before Interest and Taxes (EBITDA)1,054
 
After tax Income (+$)
Income Before Tax1,054
Tax Provision-0
Net Income From Continuing Ops01,054
Net Income845
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses5,039
Total Other Income/Expenses Net800
 

Technical Analysis of PharmChem Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of PharmChem Inc. The general trend of PharmChem Inc is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine PharmChem Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of PharmChem Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 3.1173457300276 < 3.3 < 3.4.

The bearish price targets are: 3.0243 > 2.6527 > 2.3356515384615.

Tweet this
PharmChem Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of PharmChem Inc. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

PharmChem Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of PharmChem Inc. The current macd is -0.1058134.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the PharmChem Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for PharmChem Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the PharmChem Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
PharmChem Inc Daily Moving Average Convergence/Divergence (MACD) ChartPharmChem Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of PharmChem Inc. The current adx is 54.16.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell PharmChem Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
PharmChem Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of PharmChem Inc. The current sar is 3.43340706.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
PharmChem Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of PharmChem Inc. The current rsi is 29.59. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
PharmChem Inc Daily Relative Strength Index (RSI) ChartPharmChem Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of PharmChem Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the PharmChem Inc price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
PharmChem Inc Daily Stochastic Oscillator ChartPharmChem Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of PharmChem Inc. The current cci is -87.85949704.

PharmChem Inc Daily Commodity Channel Index (CCI) ChartPharmChem Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of PharmChem Inc. The current cmo is -51.6295861.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
PharmChem Inc Daily Chande Momentum Oscillator (CMO) ChartPharmChem Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of PharmChem Inc. The current willr is -85.71428571.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
PharmChem Inc Daily Williams %R ChartPharmChem Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of PharmChem Inc.

PharmChem Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of PharmChem Inc. The current atr is 0.04387258.

PharmChem Inc Daily Average True Range (ATR) ChartPharmChem Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of PharmChem Inc. The current obv is -303,673.

PharmChem Inc Daily On-Balance Volume (OBV) ChartPharmChem Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of PharmChem Inc. The current mfi is 61.73.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
PharmChem Inc Daily Money Flow Index (MFI) ChartPharmChem Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for PharmChem Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-21ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-10-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-15ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-25ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

PharmChem Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of PharmChem Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.594
Ma 20Greater thanMa 503.263
Ma 50Greater thanMa 1003.426
Ma 100Greater thanMa 2003.379
OpenGreater thanClose3.100
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of PharmChem Inc with someone you think should read this too:
  • Are you bullish or bearish on PharmChem Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about PharmChem Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about PharmChem Inc

I send you an email if I find something interesting about PharmChem Inc.


Comments

How you think about this?

Leave a comment

Stay informed about PharmChem Inc.

Receive notifications about PharmChem Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.